Kasper CK - Search Results

1

The intron-22-inverted F8 locus permits factor VIII synthesis: explanation for low inhibitor risk and a role for pharmacogenomics.

Sauna ZE, Lozier JN, Kasper CK, Yanover C, Nichols T, Howard TE. Sauna ZE, et al. Among authors: kasper ck. Blood. 2015 Jan 8;125(2):223-8. doi: 10.1182/blood-2013-12-530113. Epub 2014 Nov 18. Blood. 2015. PMID: 25406352 Free PMC article. Review.

2

Use of porcine factor VIII for surgical procedures in hemophilia A patients with inhibitors.

Lozier JN, Santagostino E, Kasper CK, Teitel JM, Hay CR. Lozier JN, et al. Among authors: kasper ck. Semin Hematol. 1993 Apr;30(2 Suppl 1):10-21. Semin Hematol. 1993. PMID: 8480192 Review.

3

Haemophilia management: time to get personal?

Howard TE, Yanover C, Mahlangu J, Krause A, Viel KR, Kasper CK, Pratt KP. Howard TE, et al. Among authors: kasper ck. Haemophilia. 2011 Sep;17(5):721-8. doi: 10.1111/j.1365-2516.2011.02517.x. Epub 2011 Jun 8. Haemophilia. 2011. PMID: 21649795 Free PMC article. Review.

4

Inhibitors of factor VIII in black patients with hemophilia.

Viel KR, Ameri A, Abshire TC, Iyer RV, Watts RG, Lutcher C, Channell C, Cole SA, Fernstrom KM, Nakaya S, Kasper CK, Thompson AR, Almasy L, Howard TE. Viel KR, et al. Among authors: kasper ck. N Engl J Med. 2009 Apr 16;360(16):1618-27. doi: 10.1056/NEJMoa075760. N Engl J Med. 2009. PMID: 19369668 Free PMC article.

5

Hemophilia: a cautionary status report.

Kasper CK. Kasper CK. Blood. 2016 Jun 16;127(24):2949-50. doi: 10.1182/blood-2016-03-707117. Blood. 2016. PMID: 27313325 Free article. No abstract available.

6

Phenotypes of allo- and autoimmune antibody responses to FVIII characterized by surface plasmon resonance.

Lewis KB, Hughes RJ, Epstein MS, Josephson NC, Kempton CL, Kessler CM, Key NS, Howard TE, Kruse-Jarres R, Lusher JM, Walsh CE, Watts RG, Ettinger RA, Pratt KP; PATH (Personalized Alternative Therapies for Haemophilia) Study Investigators. Lewis KB, et al. PLoS One. 2013 May 8;8(5):e61120. doi: 10.1371/journal.pone.0061120. Print 2013. PLoS One. 2013. PMID: 23667433 Free PMC article.

7

Functional consequences of an arginine180 to glutamine mutation in factor IX Hilo.

Monroe DM, McCord DM, Huang MN, High KA, Lundblad RL, Kasper CK, Roberts HR. Monroe DM, et al. Among authors: kasper ck. Blood. 1989 May 1;73(6):1540-4. Blood. 1989. PMID: 2713493 Free article.

8

Safety profile of porcine factor VIII and its use as hospital and home-therapy for patients with haemophilia-A and inhibitors: the results of an international survey.

Hay CR, Lozier JN, Lee CA, Laffan M, Tradati F, Santagostino E, Ciavarella N, Schiavoni M, Fukui H, Yoshioka A, Teitel J, Mannucci PM, Kasper CK. Hay CR, et al. Among authors: kasper ck. Thromb Haemost. 1996 Jan;75(1):25-9. Thromb Haemost. 1996. PMID: 8713775

9

Molecular defect in factor IXHilo, a hemophilia Bm variant: Arg----Gln at the carboxyterminal cleavage site of the activation peptide.

Huang MN, Kasper CK, Roberts HR, Stafford DW, High KA. Huang MN, et al. Among authors: kasper ck. Blood. 1989 Feb 15;73(3):718-21. Blood. 1989. PMID: 2563663 Free article.

10

Frequency of inhibitor development in haemophiliacs treated with low-purity factor VIII.

Addiego J, Kasper C, Abildgaard C, Hilgartner M, Lusher J, Glader B, Aledort L. Addiego J, et al. Lancet. 1993 Aug 21;342(8869):462-4. doi: 10.1016/0140-6736(93)91593-b. Lancet. 1993. PMID: 8102429

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

140 results

Search Page